Andrew Saik - 21 Jun 2023 Form 4 Insider Report for INTERCEPT PHARMACEUTICALS, INC.

Role
EVP & Chief Financial Officer
Signature
/s/ Rocco Venezia, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
21 Jun 2023
Net transactions value
-$10,660
Form type
4
Filing time
23 Jun 2023, 16:04:29 UTC
Previous filing
23 Mar 2023
Next filing
25 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICPT Common Stock Tax liability $10,660 -908 -1.3% $11.74 69,173 21 Jun 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.